Descriptive research in type-I diabetes has revealed insulin Degludec destined protective having declined hypoglycemic rate and equivalent glycemic control toward insulin glargine (analog) with long-lasting activity [96]. The gene discussed is INS; the disease is type 1 diabetes mellitus.